Suthar, Mehul S.
Emory University School of Medicine,
United States
2025 Rank: 68109
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 225 out of 75944 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68109 | 60874 |
| Total Cites | 1826 | 2126 |
| H-index | 21 | 23 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 78 | 85 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 327 | 378 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1534 | 1664 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.28 |
| Self-Citation Percentage |
14.11%
|
|
Suthar, Mehul S.
Emory University School of Medicine,
United States
2024 Rank: 51458
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 198 out of 71672 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51458 | 54907 |
| Total Cites | 2609 | 2901 |
| H-index | 26 | 26 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 105 | 116 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 484 | 532 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2175 | 2316 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.25 |
| Self-Citation Percentage |
10.07%
|
|
Suthar, Mehul S.
Emory University,
United States
2023 Rank: 44207
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 213 out of 68279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44207 | 46546 |
| Total Cites | 3417 | 3780 |
| H-index | 27 | 28 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 143 | 157 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 548 | 613 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2730 | 2896 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.31 |
| Self-Citation Percentage |
9.60%
|
|
Suthar, Mehul S.
Emory University,
United States
2021 Rank: 113549
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 710 out of 64670 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113549 | 124936 |
| Total Cites | 1472 | 1606 |
| H-index | 18 | 18 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 172 | 197 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 435 | 480 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1329 | 1424 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
8.34%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.